Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8 + T Cell Exhaustion

Cited by (867)

Items 601–700 of 867

  1. Hepatitis C Virus as a Unique Human Model Disease to Define Differences in the Transcriptional Landscape of T Cells in Acute versus Chronic Infection
    David Wolski, Georg M. Lauer · 2019 · Viruses
  2. IL-15 re-programming compensates for NK cell mitochondrial dysfunction in HIV-1 infection
    Elia Moreno Cubero, Stefan Balint, Aljawharah Alrubayyi, Ane Ogbe, Rebecca Matthews, Fiona M. Burns, Sarah Rowland‐Jones, Persephone Borrow, Anna Schurich, Michael Loran Dustin et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  3. Novel treatments using PD1 inhibitors for advanced and metastatic cutaneous squamous cell carcinoma
    Saharnaz Pezeshki, Sara Hemmati, Nima Rezaei · 2020 · Expert Review of Anticancer Therapy
  4. Cure of chronic hepatitis C virus infection after DAA treatment only partially restores the functional capacity of exhausted T cell subsets: a systematic review
    Ása Didriksen Apol, Christina Søhoel Sølund, Caroline Vinten, Alexander P. Underwood, Jens Bukh, Nina M Weis · 2025 · Frontiers in Immunology
  5. Targeting the hypoxia signaling pathway with nanomedicine to reverse immunotherapy resistance
    Xiaoliang Cheng, Peixing Wang, Hongqiang Lyu, Yonghyun Lee, Juyoung Yoon, Haiyan Dong · 2025 · Cancer Drug Resistance
  6. Mitochondrial Dysfunction in Aging, HIV, and Long COVID: Mechanisms and Therapeutic Opportunities
    M. Victoria Delpino, Jorge Fabián Quarleri · 2025 · Pathogens
  7. Metabolic Reprogramming and CD8+ T‐Cell Exhaustion During Chronic HBV Infection
    Haohao Li, Wei-Wei Mu, Alison Zhao, Su Xiao, Chenxin Huo, Huajun Zhao, Hong-Chun Wang, Ronghui Li, Qiu-Ju Han · 2025 · Liver international (Print)
  8. Metabolomic profiling reveals the potential of fatty acids as regulators of exhausted CD8 T cells during chronic viral infection
    Katelynn R. Kazane, Lara Labarta-Bajo, Dina Zangwill, Kalle Liimatta, Fernando Vargas, Kelly C. Weldon, PC Dorrestein, Elina I. Zúñiga · 2026 · Proceedings of the National Academy of Sciences
  9. Metabolic traits of T cells and the implications in autoimmune diseases
    Yi Zhou, YX Zhou, Qing Zhu, Weinan Guo, Chunying Li · 2026 · Autoimmunity Reviews
  10. NR2F6 deletion revives CAR-T cell function and induces antigen-agnostic immune memory in solid tumors
    Dominik Humer, V. Klepsch, D. Rieder, Isabel Hölzl, Daniel Schreiber, Viktor Lang, Jiří Koutník, Sebastian Peer, Tajana Sajinovic, Viana Wille et al. · 2026 · Nature Communications
  11. Mitochondrial dysfunction in immune cells during the perioperative period: mechanisms, emerging therapeutic strategies, and implications for multi-organ protection
    Ziyu Wang, L. E. Wang, Maolin Ji, 娄杰, Yuchuan Yuan, Yuanxu Cui, Gang Xiang, Xin‐Fu Zhou · 2026 · Frontiers in Immunology
  12. Selective loss of CD107a TIGIT+ memory HIV-1-specific CD8+ T cells in PLWH over a decade of ART
    Oscar Blanch-Lombarte, Dan Ouchi, Esther Jiménez‐Moyano, Julieta Carabelli, Miguel Ángel Marín, Ruth Peña, Adam Nicolas Pelletier, Aarthi Talla, Ashish Sharma, Judith Dalmau et al. · 2023 · eLife
  13. Increased functional potency of multi-edited CAR-T cells manufactured by a non-viral transfection system
    Aine O’Sullivan, Sarah Case, Aisling McCrudden, Emer E. Hackett, Louise Gallagher, Darren Martin, Gillian P. Johnson, Kirti Mahadik, Thomas Kienzle, Jude Kevin Lim et al. · 2024 · Molecular Therapy — Methods & Clinical Development
  14. Mass spectrometry imaging reveals spatial metabolic variation and the crucial role of uridine metabolism in liver injury caused by Schistosoma japonicum
    Qingkai Xue, Xiangyu Zhou, Yuyan Wang, Yiyun Liu, Xiaojing Li, Chunrong Xiong, Xinjian Liu, Yuzheng Huang · 2025 · PLoS neglected tropical diseases
  15. Epigenetics and Medicine
    Giuseppe Cocco, Philipp Amiet · 2021 · OBM Genetics
  16. Interplay Between Metabolic Sensors and Immune Cell Signaling
    Prashant Singh Chauhan, Arup Sarkar, Bhaskar Saha · 2018 · Experientia supplementum
  17. Checkpoint inhibitor blockade and epigenetic reprogrammability in CD8+ T-cell activation and exhaustion
    José Ernesto Belizário, Maria Fernanda Setúbal Destro Rodrigues · 2020 · Therapeutic Advances in Vaccines and Immunotherapy
  18. Optimizing CAR-T Therapy for Glioblastoma
    Oliver Young Tang, Zev A. Binder, Donald M. O’Rourke, Stephen Joseph Bagley · 2023 · Molecular Diagnosis & Therapy
  19. Programmed T cell differentiation: Implications for transplantation
    Rebecca L. Crepeau, Mandy L. Ford · 2020 · Cellular Immunology
  20. Interleukin-7 promotes CD8+ T cell activity in patients with enterovirus 71 associated encephalitis
    Xiao‐Jun Tian, Zhou Su, Shuangxi Guo, Congcong Wang, Xueying Zhang, Jia Du · 2019 · International Immunopharmacology
  21. Obesity and Breast Cancer: Expanding the Hypothesis Space
    Ana Elisa Lohmann, Pamela Jean Goodwin · 2020 · JNCI Journal of the National Cancer Institute
  22. NRF2-dependent regulation of the prostacyclin receptor PTGIR drives CD8 T cell exhaustion
    Michael S. Dahabieh, Lisa M. DeCamp, Brandon M. Oswald, Susan M. Kitchen-Goosen, Zhen Fang Fu, Matthew Vos, Shelby E. Compton, Joseph Longo, Kelsey S. Williams, Abigail E. Ellis et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  23. DGAT1 mediates sex-specific CD8+ T cell antitumour responses
    Alaa Madi, Hui Shi, Min Su, Ahmed Mady, Boqiong Lv, Haiyan Wang, Bing Yang, Zhenni Yan, Xiaomeng Jin, Lingling Wu et al. · 2026 · Nature Metabolism
  24. Programming regulated cell death to engineer whole-tumor-cell vaccines for cancer immunotherapy
    Yingchao Guan, Die Bai, Na Bu, Wenhui Hao, Yasen Maimaitiyiming · 2026 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  25. Miltefosine reinvigorates exhausted T cells by targeting their bioenergetic state
    Xingying Zhang, Chenze Zhang, Shan Lu, Jingxi Dong, Na Tang, Yao Wang, Weidong Han, Xi Pan, Xiang Zhang, Duan Liu et al. · 2024 · Cell Reports Medicine
  26. NGR-modified curcumin nanovesicles reverse immunotherapy resistance in triple-negative breast cancer via TLR9 and mTOR pathway modulation
    Shuo Wang, Xiaoou Wang, Xinyu Zheng, Haiyang Jiang, Lu Liu, Ningye Ma, Xiaoshen Dong · 2025 · Cell Biology and Toxicology
  27. Advances in CAR-T cell therapy for refractory diseases: challenges, innovations, clinical breakthroughs, and future prospects
    Qibin Liao, Yunyu Mao, Meiqi Feng, Nairong Zheng, Xiangqing Ding, Xiaoyan Zhang, Zhongfang Wang, Jianqing Xu · 2025 · Clinical Cancer Bulletin
  28. Cross-disease communication between cancer and heart failure provides a rational approach to prevention and treatment of both diseases
    Shingo Takada, Shintaro Kinugawa, Haruka Handa, Takashi Yokota, Hisataka Sabe · 2022 · Frontiers in Oncology
  29. A Novel Immune-Related Signature to Predict Prognosis and Immune Infiltration of Cervical Cancer
    Yun Lin, Rendong Zhang, Hongchao Pan, Yaochen Li · 2023 · Medical Science Monitor
  30. Advances in Vaccines, Checkpoint Blockade, and Chimeric Antigen Receptor-Based Cancer Immunotherapeutics
    Disha Agarwal, Gaurav Sharma, Alka Khadwal, Devinder Toor, Pankaj Malhotra · 2024 · Critical Reviews in Immunology
  31. T Cell Exhaustion in Allergic Diseases and Allergen Immunotherapy: A Novel Biomarker?
    Qingxiu Xu, Le Li, Rongfei Zhu · 2025 · Current Allergy and Asthma Reports
  32. IL-15-Activated CD38+HLA-DR+CD8+ T cells induce liver injury in cirrhosis via JAK/STAT5 and PI3K/mTOR pathways
    Kebin Liu, Hongliang Dong, Kaiyue Zhang, Wanping Yan, Huanyu Wu, Jing Fan, Wei Ye · 2025 · Scientific Reports
  33. Single-cell technologies to dissect heterogenous immune cell therapy products
    Katherine P. Mueller, Krishanu Saha · 2021 · Current Opinion in Biomedical Engineering
  34. CD5 Deficiency Alters Helper T Cell Metabolic Function and Shifts the Systemic Metabolome
    Kiara V. Whitley, Claudia M. Tellez Freitas, Carlos Mauricio Moreno, Christopher Haynie, Joshua Bennett, John C. Hancock, Tyler D. Cox, Brett E Pickett, K. Scott Weber · 2022 · Biomedicines
  35. Mitochondrial dysfunction and drug targets in multiple myeloma
    Yushan Cui, Fujue Wang, Baijun Fang · 2023 · Journal of Cancer Research and Clinical Oncology
  36. Toward a new stage of PD-1 blockade cancer immunotherapy
    Nagahiro Minato · 2020 · International Journal of Clinical Oncology
  37. Instruction of Immunometabolism by Adipose Tissue: Implications for Cancer Progression
    Remya Raja, Christopher W. Wu, Francesca Limbeck, Kristina A. Butler, Abhinav P. Acharya, Marion Curtis · 2021 · Cancers
  38. Metabolomic Profiling Reveals Potential of Fatty Acids as Regulators of Stem-like Exhausted CD8 T Cells During Chronic Viral Infection
    Katelynn R. Kazane, Lara Labarta-Bajo, Dina Zangwill, Kalle Liimatta, Fernando Vargas, Kelly C. Weldon, Pieter C. Dorrestein, Elina I. Zúñiga · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Unveiling the Nexus of CD38 Overactivation, NAD+ Depletion, and Mitochondrial Dysfunction in Immunological Failure Among Virologically Suppressed HIV Patients
    Martin L. Gnoni · 2024 · Norton Healthcare Medical Journal
  40. The multifaceted landscape of T cell exhaustion in organ transplantation: From molecular mechanisms (epigenetics, transcription, metabolism) to induction strategies
    Yining Wang, You Wu, Yufei Shen, Yujia Chen, Yifan Zhao, Xiandong Zeng, Kang He · 2025 · Genes & Diseases
  41. T Cell Exhaustion in Hepatocellular Carcinoma: A Substantial Barrier in Immunotherapy
    Kosar Nouri, Negar Aasadollahei, Yasamin Haghir-Sharif-Zamini, Homeyra Seydi, Mahsa Salehi, Mehrnaz Mesdaghi, Mustapha Najimi, Massoud Vosough · 2026 · Journal of Cellular and Molecular Medicine
  42. VISTA drives pancreatic tumor progression through modulation of the tumor-associated macrophage polarity
    Suk-kyung Shin, Gwanghun Kim, Su Min Park, Eun-Bi Seo, Sang-Kyu Ye, Gyeong Hoon Kang, Keehoon Jung, Hyun Mu Shin, Hang‐Rae Kim, Dong‐Sup Lee · 2026 · Nature Communications
  43. Dual-targeting strategies for cancer and diabetes: Converging pharmacological pathways and repurposed therapies
    Gurjit Kaur Bhatti, Ishtiaq Ahmed, Abhishek Sehrawat, Pushpender Kumar Sharma, Ramesh Kandimalla, Jasvinder Singh Bhatti, Jasvinder Singh Bhatti · 2026 · Molecular Aspects of Medicine
  44. CD8+ TEMRA cells: A double-edged sword in immunity and disease—Mechanisms and therapeutic targets
    Jiajin Ma, Yinyin Wu, Lujun Chen, Xiao Zheng · 2026 · International Immunopharmacology
  45. T cell exhaustion landscapes and therapeutic modulation in cancer immunity
    Jhommara Bautista, Andrés López‐Cortés · 2026 · Frontiers in Cell and Developmental Biology
  46. Glucose metabolic reprogramming as a driver of immunosuppression in the tumour microenvironment
    Yang Wang, Yijun Lu, Jian Zhou, Xinrong Yang · 2026 · Clinical and Translational Medicine
  47. Mastering an exhausting marathon: how CD8+ T cells fine‐tune metabolic fitness
    Anna M. Schulz, Dietmar Zehn · 2022 · Immunology and Cell Biology
  48. Distinguishing the pros and cons of metabolic reprogramming in oncolytic virus immunotherapy
    Shiqun Wang, Jiwu Wei · 2022 · International Journal of Cancer
  49. Immune regeneration: implications for cancer immunotherapy and beyond
    Steven L. Reiner · 2025 · Journal of Clinical Investigation
  50. Metabolic profiling of antigen-specific CD8+ T cells by spectral flow cytometry
    Nils Mülling, J. Fréderique de Graaf, Graham A. Heieis, Kristina Boss, Benjamin Wilde, Bart Everts, Ramon Arens · 2025 · Cell Reports Methods
  51. Feeling stressed? It might be your T cells
    Laura Strauss, Nikolaos Patsoukis, Vassiliki A. Boussiotis · 2017 · Nature Immunology
  52. Success of immune checkpoint blockade therapies – mechanisms and implications for hepatology
    Bertram Bengsch, Robert Thimme · 2019 · Zeitschrift für Gastroenterologie
  53. Immune Mechanisms of Viral Clearance and Disease Pathogenesis During Viral Hepatitis
    Carlo I. Ferrari, Valeria Barili, Stefania Varchetta, Mario Umberto Mondelli · 2020 · Wiley eBooks
  54. Metabolic Deficiencies Underlie Plasmacytoid Dendritic Cell Exhaustion After Viral Infection
    Trever T. Greene, Yeara Jo, Mónica Macal, Ziyan Fang, Fawziyah S. Khatri, Alicia L Codrington, Katelynn R. Kazane, Carolina Chiale, Elizabeth Akbulut, Shobha Swaminathan et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Longitudinal Proteomic Profiling of T Cell Differentiation In Vivo Reveals Biochemical Remodeling Underlying Exhaustion
    Christian Michel Beusch, Abdelhameed S. Dawood, Ahmet Ozdilek, Sarah Welbourn, Youssef M. Zohdy, Christopher M. Monaco, Alexandra S. Flegle, Ahmed Mahgoub, Sakshi Malik, Christina Niavi et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  56. Biosynthetic plasticity enables CD8+ T cell functional resilience under nutrient stress
    Michael Scaglione, Montana Knight, Krittin Trihemasava, Kelly Rome, Anne‐Sophie Archambault, Ju‐Hee Oh, Erin Tanaka, Elise Hall, Tran Ngoc Van Le, Caleb L. Lines et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  57. Skin-Resident γδ T Cells Mediate Potent and Selective Antitumor Cytotoxicity through Directed Chemotactic Migration and Mobilization of Cytotoxic Granules
    Jiacai Yang, Zhihui Liu, Xiaohong Hu, Xiaorong Zhang, Yong Huang, Yunxia Chen, Cheng Chen, Ruoyu Shang, Yuanyang Tang, Wengang Hu et al. · 2024 · Journal of Investigative Dermatology
  58. Development of therapeutic cancer vaccines based on cancer immunity cycle
    Jing Zhang, Yiyuan Zheng, Lili Xu, Jing Gao, Zhuoyu Ou, Mingzhao Zhu, Wenjun Wang · 2025 · Frontiers of Medicine
  59. Mitochondrial mass and low mitochondrial membrane potential percentage of CD8+ T cell subsets are implicated with therapeutic effect in depressive disorder
    Yiran Huang, Zhenni Chen, Xu Yang, Biqiong Ren · 2025 · Frontiers in Psychiatry
  60. Loss of Bcl6 promotes antitumor immunity by activating glycolysis to rescue CD8 T-cell function
    Fangkun Luan, Yunqiao Li, Jia Ning, Jenny Tuyet Tran, Tanya R. Blane, Raag Bhargava, Zhe Huang, Changchun Xiao, David A. Nemazee · 2025 · Life Science Alliance
  61. Immune and non-immune cell fencing of tumor cells is a widespread and functionally relevant spatial pattern in solid cancers
    Giuseppe Giuliani, Dhruv Chavan, Rushil Gaddam, William C. Stewart, Zihai Li, Ciriyam Jayaprakash, Jayajit Das · 2025 · Computational and Structural Biotechnology Journal
  62. Hepatocellular Carcinoma – from Immunobiology to Immunotherapy
    Natascha Roehlen, Bertram Bengsch, Charlotte Rennert, Michael Schultheiß, Robert Thimme · 2026 · Zeitschrift für Gastroenterologie
  63. Integrating Three Functional Subsets of T Cell Immunity Into an Integrative Model for Cancer Immunotherapy
    J O Park, Heeju Ryu · 2026 · Immune Network
  64. Myeloid-derived immunosuppression of chimeric antigen receptor T cells in the neuronal microenvironment of glioblastoma
    Junyi Zhang, Jasmin von Ehr, Thomas Look, Jasim Kada Benotmane, Nicolas Noel Neidert, Jan Kueckelhaus, Tobias Weiß, Dieter Henrik Heiland, Yahaya Abubakar Yabo · 2026 · BMC Medicine
  65. Immune exhaustion in bacterial infections: mechanisms, consequences, and therapeutic implications
    Saeed Hemati, Zeinab Mohsenipour · 2026 · The Brazilian Journal of Infectious Diseases
  66. Overexpression of HIF-1α via small activating RNA enhances CAR-T cell function in hypoxic microenvironments
    Na Huang, Qi Chen, Xiqian Zhang, Muhammad Asad Farooq, Wanjun He, Kai Cui, Songshan Zhu, Iqra Ajmal, Dan Jiang, Guangxian Xu · 2026 · Pharmacological Research
  67. Engineering strategies and binding mechanisms of therapeutic anti–PD-1 antibodies approved by regulatory agencies globally
    Juan Carlos Almagro, Keyla Gómez-Castellano, Ileana Licona‐Limón, Gregorio Carballo‐Uicab, Frida Ramírez-Villedas, Alejandra Montes-Luna, Edith González‐González, Silvia Godínez-Palma, Hugo Alberto Barrera-Saldaña, Sonia Mayra Pérez‐Tapia · 2026 · Frontiers in Immunology
  68. Mitochondrial transfer-driven immune evasion in the tumor microenvironment
    Li Zhu, Yosuke Togashi · 2026 · International Immunology
  69. Next-generation CAR-T combinations: Integrating nanomedicine, metabolic reprogramming, and AI for solid tumor targeting
    S R Krupesha Sharma, Sobin Saha, Swati Arora, Yogesh K Ahlawa, Sumit Sheoran, Srestha Mukherjee, Astha Sinha, Kirti Chaudhary, Sunil Babu Gosipatala · 2026 · Disease and Therapeutics
  70. Mitochondrial transfer in the tumor microenvironment: a dynamic determinant of cancer plasticity, immune dysfunction, and therapeutic opportunity
    Zhenyuan Xu, Qingli Zhou, Jifei Miao · 2026 · Frontiers in Immunology
  71. Adenosine as a metabolic checkpoint in CD8+ T cell dysfunction
    Arden O. Edgerton, Mauricio J. Reginato, Michele A. Kutzler, Elias K. Haddad · 2026 · Trends in Immunology
  72. T cell senescence and exhaustion: molecular mechanisms and immune rejuvenation for cancer immunotherapy
    Lauren van den Broecke, Arne Van der Vreken, Fenja Watté, Fien Meeus, Kim De Veirman, Karine Breckpot, Elke De Bruyne, Eline Menu · 2026 · Signal Transduction and Targeted Therapy
  73. Modulating Immune Response in Viral Infection for Quantitative Forecasts of Drug Efficacy
    Bárbara Costa, N. Vale · 2023 · Pharmaceutics
  74. Energy demanding RNA and protein metabolism drive dysfunctionality of HIV-specific T cell changes during chronic HIV infection
    Lisa van Pul, Melissa Stunnenberg, Stefanie Kroeze, Karel A. van Dort, Brigitte Boeser‐Nunnink, Agnes M. Harskamp, Teunis B. H. Geijtenbeek, Neeltje A. Kootstra · 2024 · PLoS ONE
  75. Ubiquitination in the T Cell Metabolism-Based Immunotherapy in Diseases
    Ke-qi Fan, Yi‐yuan Li, Jin Jin · 2024 · Advances in experimental medicine and biology
  76. Myoglobin expression improves T-cell metabolism and antitumor effector function
    Julia Werner, Haifeng Xu, Georgios Theodorakis, Ichiro Katahira, Mitrajit Ghosh, Michał Gorzkiewicz, Luisa de Sousa Santos, Ann Kathrin Bergmann, Max Anstötz, Anne Busch et al. · 2025 · Journal for ImmunoTherapy of Cancer
  77. Angry, Hungry T-Cells: How Are T-Cell Responses Induced in Low Nutrient Conditions?
    Francesco Nicoli · 2020 · Immunometabolism
  78. Is T Cell Exhaustion a Treatable Trait in Sepsis?
    Matthew Fish, Chad M. Swanson, Manu Shankar‐Hari · 2020 · Annual update in intensive care and emergency medicine
  79. Immunometabolism and Its Potential to Improve the Current Limitations of Immunotherapy
    Andrew D. Sheppard, Joanne Lysaght · 2020 · Methods in molecular biology
  80. A Novel Strategy to Fuel Cancer Immunotherapy: Targeting Glucose Metabolism to Remodel the Tumor Microenvironment
    Xu Liu, Yujie Zhao, Xi Wu, Zhihui Liu, Xiaowei Liu · 2022 · Vide Leaf, Hyderabad eBooks
  81. PD-L1-expressing astrocytes act as a gate-keeper for neuroinflammation in the central nervous system of mice with traumatic brain injury
    Xiang Gao, Wei Li, Fahim Syed, Fang Yuan, Ping Li, Qigui Yu · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  82. BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved antitumor activity
    Taylor L. Hickman, Eugene Choi, Kathleen R. Whiteman, Sujatha Muralidharan, Tapasya Pai, Tyler Johnson, Avani Bharat Parikh, Taylor Friedman, Madaline Gilbert, Binzhang Shen et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  83. Accelerated Aging process in Patients Living with HIV: Role of Mitochondrial Dysfunction.
    Martin L. Gnoni · 2024 · Norton Healthcare Medical Journal
  84. MitoTempo treatment as an approach to cure persistent viral infections?
    Jasmin Mischke, Sebastian Klein, Markus Cornberg, Anke R.M. Kraft · 2024 · Virology
  85. Follicular cytotoxic T cells is dysfunctional in chronic hepatitis B patients with non-alcoholic fatty liver disease
    Daixi Jiang, Xiaoyue Wu, Can Chen, Tao Ju, Yuxia Du, Mengya Yang, Kexin Cao, Mengsha Chen, Wenkai Zhou, Jiaxing Qi et al. · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  86. MEK-dependent bioenergetic demand drives terminal CD8+ T cell exhaustion
    Tanya Mitra, Jahan A. Rahman, Madeline A. Hwee, Yan-Ting Chen, Ruben Jose Jesus Faustino Ramos, Hui Liu, Travis E. Hartman, Justin R. Cross, Miguel de Jesus, Morgan Huse et al. · 2026 · Immunity
  87. Lipids rewire T cell exhaustion
    Marie-Elen Tuchel, Annette Oxenius · 2025 · Nature Immunology
  88. Stem-like CD4+ T cells mediate T-cell state transitions to enhance tumor control and immunotherapy response
    Mamali Das, Chandramohan Kiruthiga, K. T. Nachammai, Dipali Desai, William Chi Shing Cho, Chandrabose Selvaraj, Langeswaran Kulanthaivel · 2025 · International Immunopharmacology
  89. Exhaustion‐Resistant CD8 + T Cells in Ankylosing Spondylitis: A Proposed Three‐Axis Model
    Xuhong Zhang, Jia Lu, Xueni Lin, Lamei Zhou · 2025 · Immunology
  90. Integrated single-cell and bulk RNA sequencing analysis reveals ACACA as a potential prognostic and immunotherapeutic biomarker across cancers
    H H He, Zhen Zhang, Leifeng Chen, Fushan Gao, Yuze Wu, Lina Yi, Fei Shao, Yibo Gao, Jie He · 2025 · Frontiers in Immunology
  91. Metabolic Reprogramming of Adaptive Immunity Induced by Viral Infections
    Guoshuai Tong, Jingwen Dai, Qianqian Liu, Xu Gao, Su Li, Hua‐Ji Qiu · 2025 · Immunology
  92. Identifying endoplasmic reticulum stress-related key genes of vascular dementia using bioinformatics and biological experiments
    Yilong Zhao, Wen Xing, Li Jiang, Xiangrong Liu, Hui Qu, Weiqi Chen, Yilong Wang · 2026 · Biochemical and Biophysical Research Communications
  93. Nervous and immune system crosstalk shapes cancer progression and treatment response
    Mustafa TArdah, Raghda AliBakr, H. Malathi, Vimal Arora, Priya Priyadarshini‐Nayak, Dilbar Urazbaeva, Mukhayya Xusinovna Djumaniyazova, Sadullayeva Moxinur, Farid KarkonShayan · 2026 · Discover Oncology
  94. Metabolic Landscape and Emerging Therapeutic Potential in Pediatric and Adult Gliomas
    Cayley S. Brock, Lam Nguyen, C Pattillo, Cheyenne Ahamed, Keisaku Sato, Kevin K. Kumar · 2026 · International Journal of Molecular Sciences
  95. Acute and chronic infections drive distinct trajectories in human memory CD4+ T cell formation
    Matthias Reinscheid, J Weißer, N Pascual Maier, David B. Reeg, P L Hafkemeyer, Lara Kelsch, Giuseppe Rusignuolo, Jakob Arnold, Florian Emmerich, Andreas Walker et al. · 2026 · Immunity
  96. Microglia Reprogramming in Glioblastoma: Stem Cell-Derived Factors as Emerging Immunomodulators
    Zahra Amiri, Beatrice Federica Tremonti, Alessandro Corsaro, Alessandra Pattarozzi, Adriana Bajetto, Federica Barbieri, Stefano Thellung, Tullio Florio · 2026 · Cells
  97. T‐Cell Exhaustion in the Tumor Microenvironment: Subcellular Dysfunction, Pan‐Cancer Characteristics, and Therapeutic Interventions
    Mingxing Wang, Wanhui Dong, Jian Chen, Zhangjie Zhou, Shujuan Fu, Tingting Wu, Haiyan Jiang, Z Wang, Zhixian Zhong, Yi Zhong · 2026 · Advanced Science
  98. Therapeutic targeting of IL-17A–driven PTGS2/NLRP3 inflammasome activation in juvenile myelomonocytic leukemia
    Santhosh Kumar Pasupuleti, Baskar Ramdas, Kanaka Sai Ram Padam, Rahul Kanumuri, Lakshmi Reddy Palam, Ramesh Kumar, Tzu‐Chieh Ho, Alex Gia Lee, D. Wade Clapp, Cheng‐Kui Qu et al. · 2026 · Blood
  99. Reprogramming the tumor microenvironment via TFF3 targeting: a potential novel avenue to boost CAR-T cell therapy in solid tumors
    Arman Rahimi, Ghasem Solgi, Mehrnoush Safarzadeh, Pantea Mohammadi, Mohsen Rastegari‐Pouyani · 2026 · Cancer Gene Therapy
  100. T Cell Exhaustion as a Regulated Differentiation Programme
    Marc Veldhoen, Cristina Ferreira · 2026 · European Journal of Immunology